While premature death in schizophrenia is well recognised, mortality risk has received little
longitudinal study in relation to population representativeness and patient engagement with …

BackgroundThis paper presents a structured review of the published information on the
mortality of schizophrenia. MethodA meta-analysis of the literature. ResultsSchizophrenia …

BackgroundThe excess mortality of schizophrenia is well recognised, but its precise causes
are not well understood. AimsTo measure the standardised mortality ratio (SMR) and …

People with schizophrenia die 15‐20 years prematurely. Understanding mortality risk and
aggravating/attenuating factors is essential to reduce this gap. We conducted a systematic …

Objective People with schizophrenia face an increased risk of premature death from chronic
diseases and injury. This study describes the trajectory of acute care health service use in …

Objective: To compare the causes and rates of death for people with and without
schizophrenia in Manitoba, Canada. Method: Using de-identified administrative databases …

Background The introduction of second-generation antipsychotic drugs during the 1990s is
widely believed to have adversely affected mortality of patients with schizophrenia. Our aim …

Aim: We conducted a matched-cohort study to assess mortality in schizophrenia and the
relationship of mortality with comorbid somatic conditions and suicide attempts. Method: A …

BACKGROUND: We examined mortality time trends and premature mortality among
individuals with and without schizophrenia over a 20-year period. METHODS: In this …

Introduction There is increasing evidence of excess mortality in schizophrenia but less
information on other non-affective psychoses. We therefore generated standardised …